In accordance with the requirements of "Notice on Carrying out the Evaluation and Commendation Work of the Ninth Gansu Provincial People's Government Quality Award" (Gan Shijian Fa [2025] No. 72) issued by Gansu Provincial Market Supervision Administration and Gansu Provincial Human Resources and Social Security Department, after the declaration of the Heavy Ion Center and qualification review and other procedures, the center discussed and agreed that the Heavy Ion Center can participate in the evaluation of the Ninth Gansu Provincial People's Government Quality Award. It is now publicized as follows:

Gansu Province Wuwei Cancer Hospital has launched research on using carbon ion therapy to treat benign diseases such as rheumatoid arthritis, offering a new low-dose carbon ion irradiation protocol. Patients will have zero out-of-pocket expenses, fully covered by research funding. Volunteers with refractory rheumatoid arthritis are being recruited to explore new mechanisms of anti-inflammatory and immunomodulatory effects, contributing to medical advancements.

The Lanzhou Campus of Gansu Wutai Cancer Hospital has launched a clinical study on zero out-of-pocket costs for heavy ion therapy in liver cancer, initiating a Phase II trial of carbon ion radiotherapy for curative treatment of early- to mid-stage hepatocellular carcinoma. Led by a top-tier expert team, the precise treatment covers various cancers including lung and pancreatic cancer. Patients who meet the eligibility criteria are welcome to consult and register.

The Lanzhou Campus of Gansu Province Wuwei Tumor Hospital has launched a clinical study on zero out-of-pocket expenses for carbon ion therapy in cervical cancer, employing a combination of carbon ion and brachytherapy techniques. This offers precise and efficient treatment plans for locally advanced cervical cancer, led by a top-tier expert team. Patients who meet the eligibility criteria are welcome to apply.

Gansu Province Wuwei Tumor Hospital has fully launched a clinical study on zero out-of-pocket costs for low-dose carbon ion therapy in benign prostatic hyperplasia. As the only hospital globally operating two carbon ion systems, it is now publicly recruiting patients aged 60–85 to participate, offering personalized treatment plans and comprehensive follow-up care, with the aim of improving symptoms and establishing a Chinese standard for carbon ion therapy.

Gansu Province Wuwei Tumor Hospital has launched a clinical study on zero self-payment for heavy ion therapy in esophageal cancer, recruiting 32 patients in May 2025. The study employs photon combined with carbon ion radiotherapy, waiving treatment costs to explore new therapies aligned with international standards. For details and enrollment criteria, please consult Dr. Chen or Dr. Zhang.

The Gansu Province Wuwei Tumor Hospital has launched a clinical study on the use of carbon ion therapy to treat benign diseases such as rheumatoid arthritis. The cost of low-dose carbon ion treatment will be covered by research projects, with no out-of-pocket expenses for patients. Offering an innovative Chinese solution for refractory RA, we welcome volunteers who meet the criteria to participate and embark on a new hope for recovery.

Esophageal cancer is one of the most common malignant tumors worldwide, and China is a high-incidence region. According to 2015 estimates of cancer epidemiology in China, there were approximately 246,000 new cases and 188,000 deaths from esophageal cancer annually, ranking it as the sixth leading cause of cancer incidence and the fourth leading cause of cancer mortality. In China, known risk factors for esophageal cancer are closely linked to dietary habits and lifestyle, including consumption of very hot foods and beverages, alcohol drinking, and smoking. Additional contributing factors include food mold contamination, char-grilled or smoked food preparation methods, contaminated drinking water, soil composition, and environmental microbial flora.

Professor Gyoergy Kovacs from the University of Lübeck, Germany, is visiting our hospital, providing international standard personalized treatment plans. The special outpatient service on April 9, 2026, is now open for appointment, offering international medical services.

Renowned Russian radiation oncology expert Professor Andrey Kaprin will provide outpatient consultation, ward rounds and academic guidance at our hospital, offering international standard personalized treatment plans. Special outpatient appointments will be available from April 13th to 14th, providing access to top-tier radiotherapy services for tumors.